PUBLICATIONS

The list of publications is continually updated.

For more information on multi-organ support, please register for our free Literature-Service.

Respiratory and metabolic acidosis correction with the ADVanced Organ Support system

Intensive Care Medicine Experimentalvolume 7, Article number: 56 (2019). doi: 10.1186/s40635-019-0269-7

Perez Ruiz de Garibay A, Kellum J, Honigschnabel J, Kreymann B
https://icm-experimental.springeropen.com/articles/10.1186/s40635-019-0269-7
Successful therapy of massive risperidone-induced rhabdomyolysis using different dialysis and adsorber devices: A case report

Artif Organs. 2019 May 28. doi: 10.1111/aor.13479

Jarczak D, Kluge S, Fuhrmann V
https://www.ncbi.nlm.nih.gov/pubmed/31140191
Feasibility of ultrafiltration in patients treated with the ADVOS/HepaWash-device under haemodynamic monitoring with transpulmonary thermodilution (TPTD) and pulse contour analysis (PCA): The HAEMADVOS-III-study

Crit Care. 2019 Mar 19;23(Suppl 2):72

Huber W, Leinfelder M, Lahmer T, Batres-Baires G, Rasch S, Schreiber S, Schmid R
https://isicem.esn.eu/posters_listing/see_poster/178/2019/jury
Heamodynamic effects of disconnection from the "advanced organ support" (ADVOS): the HAEMADVOS-II-study evaluating the "retransfusion volume challenge option” (REVOLUTION)

Intensive Care Medicine Experimental 2018 (Suppl 2) :40

Huber W, Leinfelder M, Lahmer T, Herner A, Mayr U, Batres-Baires G, Schreiber S, Häberlein M, Habe nicht L, Schmid R
https://icm-experimental.springeropen.com/articles/10.1186/s40635-018-0201-6
The impact of connection to the extracorporeal circuit on haemodynamics (transpulmonary thermodilution (TPTD) and pulse contour analysis (PCA)) in patients treated with the ADVOS/ HepaWash-device: the HAEMADVOS-I-study

Intensive Care Medicine Experimental 2018 (Suppl 2) :40

Huber W, Leinfelder M, Lahmer T, Herner A, Mayr U, Batres-Baires G, Hartter I, Wiesner J, Schmid R
https://icm-experimental.springeropen.com/articles/10.1186/s40635-018-0201-6
Erfahrungen mit Advanced Organ Support (ADVOS) bei Patienten mit Multiorganversagen

DIVI 2018 – Abstractbuch

Fuhrmann V, Weber T, Roedl K, Tariparast A, Jarckzack D, Kluwe J, Boenisch O, Kluge S
http://react-profile.org/ebook/DIVI_2018_Abstractbuch/61/
ADVOS ahmt die Nierenkompensation des Körpers für die Behandlung der respiratorischen Azidose nach: In-vitro-Demonstration

DIVI 2018 – Abstractbuch

Ruiz de Garibay A, Honigschnabel J, Kreymann B
http://react-profile.org/ebook/DIVI_2018_Abstractbuch/62/
Das ADVOS-System: Albumin-Dialyse-basierter Ansatz zur signifikanten und kontinuierlichen Entfernung von wasserlöslichen und proteingebundenen Toxinen auch bei geringen Blutflüssen

DIVI 2018 – Abstractbuch

Ruiz de Garibay A, Honigschnabel J, Kreymann B
http://react-profile.org/ebook/DIVI_2018_Abstractbuch/63/
ADVOS kehrt die metabolische Azidose um, ohne pCO2 zu erhöhen: Proof of Concept in vitro

DIVI 2016 – Abstractbuch

Ruiz de Garibay A, Ende-Schneider B, Kreymann B
http://react-profile.org/ebook/DIVI_2018_Abstractbuch/64/
The ADVOS Device: Albumin Dialysis Based Approach for Significant and Continuous Removal of Water Soluble and Protein Bound Toxins Even at Low Blood Flows

Blood Purif 2018;46:163–186

Perez Ruiz de Garibay A, Honigschnabel J, Kreymann B
https://www.karger.com/Article/Abstract/490123
ADVOS Reverses Metabolic Acidosis Without Elevating pCO2: Proof of Concept In Vitro

Blood Purif 2018;46:163–186

Perez Ruiz de Garibay A, Ende-Schneider B, Kreymann B
https://www.karger.com/Article/Abstract/490123
ADVOS Corrects Respiratory Acidosis Mimicking the Body’s Renal Compensation: In Vitro Demonstration

Blood Purif 2018;46:163–186

Perez Ruiz de Garibay A, Ende-Schneider B, Kreymann B
https://www.karger.com/Article/Abstract/490123
ADVOS reduces liver and kidney disease markers and corrects acidosis: the Hamburg experience

Critical Care 2018 22(Suppl 1):82

Fuhrmann VH, Jarczak D, Boenisch O, Kluge S
https://ccforum.biomedcentral.com/articles/10.1186/s13054-018-1973-5
Evaluation of an ADVanced Organ Support (ADVOS) system in a two-hit porcine model of liver failure plus endotoxemia

Al-Chalabi A, Matevossian E, von Thaden A, Schreiber C et al.

Intensive Care Med Exp. 2017; 5(1):31
https://icm-experimental.springeropen.com/articles/10.1186/s40635-017-0144-3
First clinical experience in 14 patients treated with ADVOS: a study on feasibility, safety and efficacy of a new type of albumin dialysis

Huber W, Henschel B, Schmid R, Al-Chalabi A

BMC Gastroenterology 2017; 17:23
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312588/
Advanced Organ Support (ADVOS) based on albumin dialysis, a new method for CO₂ removal and pH stabilization

Perez Ruiz de Garibay A, Ende-Schneider B, Schreiber C, Kreymann B

Critical Care 2017; 21 (Suppl 1):57
http://ccforum.biomedcentral.com/articles/10.1186/s13054-017-1628-y
Combined removal of 4.5 mol/day of protons and protein bound and water soluble substances in an ex vivo model for metabolic acidosis using an Advanced Organ Support (ADVOS) system based on albumin dialysis

Perez Ruiz de Garibay A, Ende-Schneider B, Schreiber C, Kreymann B

Critical Care 2017; 21 (Suppl 1):58
http://ccforum.biomedcentral.com/articles/10.1186/s13054-017-1629-x
Anwendung eines neuartigen Hämodialyseverfahrens bei einem septischen Patienten mit hyperkapnischem Lungenversagen

Tariparast P, Roedl K, Horvatits T, Drolz A, Jarczak D, Siedler S, Kluge S, Fuhrmann V

Abstractbuch des 16. Kongress der Deutschen Interdisziplinären Vereinigung für Intensiv- und Notfallmedizin; 2016 Nov 30 –Dec 2; Hamburg. Deutschland: DIVI; 2016. Abstract EP/04/10.
http://online-divi.de/img/DIVI/content/abstracts2016.pdf?v=1
Das Advanced Organ Support (ADVOS) Verfahren in der Therapie des Multiorganversagens

Sollinger D, Dörken M, Lutz J

Abstractbuch des 16. Kongress der Deutschen Interdisziplinären Vereinigung für Intensiv- und Notfallmedizin; 2016 Nov 30 –Dec 2; Hamburg. Deutschland: DIVI; 2016. Abstract EP/06/05.
http://online-divi.de/img/DIVI/content/abstracts2016.pdf?v=1
Erste Erfahrungen mit einem neuen erweiterten Dialyseverfahren bei kritisch kranken Patienten mit Multiorganversagen

Fuhrmann V, Drolz A, Horvatits T, Roedl K, Horvatits K, Benten D, Kluwe J, Jarczak D, Tariparast P, Siedler S, Kluge S

Abstractbuch des 16. Kongress der Deutschen Interdisziplinären Vereinigung für Intensiv- und Notfallmedizin; 2016 Nov 30 –Dec 2; Hamburg. Deutschland: DIVI; 2016. Abstract EP/06/10.
http://online-divi.de/img/DIVI/content/abstracts2016.pdf?v=1
Erste Erfahrungen mit dem ADVOS-Verfahren (Advanced Organ Support) bei Patienten mit alkoholischer Steatohepatitis (ASH)

Huber W, Henschel B, Lahmer T, Braun M, Schmid R et al.

Abstractbuch des 16. Kongress der Deutschen Interdisziplinären Vereinigung für Intensiv- und Notfallmedizin; 2016 Nov 30 –Dec 2; Hamburg. Deutschland: DIVI; 2016. Abstract EP/06/12.
http://online-divi.de/img/DIVI/content/abstracts2016.pdf?v=1
Erfolgreiche Therapie einer schwerwiegenden Rhabdomyolyse nach Einnahme von Risperidon durch den Einsatz verschiedener Dialyse- und Adsorptionsverfahren (ADVOS, CVVHD, CytoSorb)

Jarczak D, Wehmeyer M, Roedl K, Tariparast P, Horvatits T, Drolz A, Rutter K, Siedler S, Kluge S, Fuhrmann V

Abstractbuch des 16. Kongress der Deutschen Interdisziplinären Vereinigung für Intensiv- und Notfallmedizin; 2016 Nov 30 –Dec 2; Hamburg. Deutschland: DIVI; 2016. Abstract EP/06/13.
http://online-divi.de/img/DIVI/content/abstracts2016.pdf?v=1
First clinical experience with a new type of albumin dialysis: the Hepa Wash system

Henschel B, Schmid R, Huber W.
Critical Care 2015; 19 (Suppl 1):P383 (16 March 2015)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471673
Fachpflege Nephrologie und Dialyse: Leberunterstützungstherapien

Kreymann B, Riedelsdorf G, Schreiber C, Breuch G, Müller E
5. Aufl. s.l.: Urban Fischer Verlag – Nachschlagewerke; 2014
http://shop.elsevier.de/fachpflege-nephrologie-und-dialyse-9783437262531.html
Evaluation of the Hepa Wash treatment in pigs with acute liver failure

Al-Chalabi A, Matevossian E, v. Thaden A, Luppa P, Neiss A, Schuster T et al.
BMC Gastroenterology 2013; 13(1):83
http://link.springer.com/article/10.1186%2F1471-230X-13-83
Leberunterstützungstherapien 2010: Mehr Fragen als Antworten

Al-Chalabi A, Kreymann B, Huber W
Intensivmedizin und Notfallmedizin. 2010; 47(8):576–81
http://link.springer.com/article/10.1007/s00390-010-0194-1
A model of ischemic isolated acute liver failure in pigs: standardizing monitoring and treatment

Al-Chalabi A, Matevossian E, Preissel A, Perren A, Yang Z et al.
European Surgical Research 2010; 45(2):86–97
http://www.karger.com/Article/Pdf/319878
Improvement of survival in a swine model of acute liver failure by a new liver support system (Hepa Wash)

Al-Chalabi A, Matevossian E, Preissel A, Yang Z, Schreiber C, Schimmel P et al.
Journal of Hepatology 2010; 52:319-320
http://www.journal-of-hepatology.eu/article/S0168-8278%2810%2960820-3/abstract
Survival improvement in pigs with liver failure and superimposed sepsis by a new liver support system (Hepa Wash)

Al-Chalabi A, Matevossian E, Preissel A, Yan H, Geiger A et al.
Critical Care 2010; 14(Suppl 1):P508
http://ccforum.biomedcentral.com/articles/10.1186/cc8740
Möglichkeiten und Zukunftsperspektiven der Leberersatztherapie

Al-Chalabi A, Kreymann B, Langgartner J, Brünnler T
Intensivmedizin und Notfallmedizin 2009; 46(5):347–54
http://link.springer.com/article/10.1007/s00390-009-0039-y
Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation

Kozik-Jaromin J, Nier V, Heemann U, Kreymann B, Böhler J
Nephrology Dialysis Transplantation 2009; 24(7):2244–51
http://www.ncbi.nlm.nih.gov/pubmed/19196824/
Grundlagen der Nieren- und Leberdialyse

Schreiber C, Al-Chalabi A, Tanase O, Kreymann B

In: Wintermantel E, Ha S-W (eds)
Medizintechnik: Life Science Engineering. Springer Berlin/Heidelberg; 2009. P 1519–84
http://www.springerlink.com/content/u544786w0371k285/
Treatment of septic patients with an arginine-based endotoxin adsorber column improves hemodynamics and reduces oxidative stress: results of a feasibility study

Umgelter A, Reindl W, Lutz J, Kreymann B, Ronco C, Huber W et al.
Blood Purif 2008; 26(4):333–9
http://www.ncbi.nlm.nih.gov/pubmed/18483452
Haemodialysis for the prevention of contrast-induced nephropathy: outcome of 31 patients with severely impaired renal function, comparison with patients at similar risk and review

Huber W, Jeschke B, Kreymann B, Hennig M, Page M et al.
Investigative radiology 2002; 37(9):471–81
https://www.ncbi.nlm.nih.gov/pubmed/12218442
Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins

Kreymann B, Seige M, Schweigart U, Kopp KF, Classen M
Journal of Hepatology 1999; 31(6):1080–5
https://www.ncbi.nlm.nih.gov/pubmed/10604583
Long-term treatment of patients with acute exacerbation of chronic liver failure by albumin dialysis

Seige M, Kreymann B, Jeschke B, Schweigart U, Kopp KF et al.
Transplantation Proceedings 1999; 31(1-2):1371–5
https://www.ncbi.nlm.nih.gov/pubmed/10083608/

Literature-Service

Would you like to get more information on the topic of multi-organ support?

Then register for our free Literature-Service.

marketing@advitos.com